Researcher
Benedicte De Winter
- Research Expertise:- Visceral pain - Inflammation - ileus - irritable bowel syndrome - IBS - inflammatory bowel disease - IBD - sepsis - experimental and clinical translational research - medisch vaardighedenonderwijs
- Keywords:VISCERAL PAIN, SEPSIS, IRRITABLE BOWEL SYNDROME, INFLAMMATION, INFLAMMATORY BOWEL DISEASE, Medicine
- Disciplines:Gastro-enterology, Inflammation, Pathophysiology
- Research techniques:- in vivo animal models of IBS, IBD and sepsis - visceromotor response and afferent neuronal activity - motility and sensitivity assays - inflammation measurements - Elisa, flowcytometry - vaardigheden, portfolio, stationsproeven
- Users of research expertise:- research labs - pharmaceutical industry - (bio-, para-) medical schools
Affiliations
- Laboratory Experimental Medicine and Pediatrics (LEMP) (Research group)
Responsible
From1 Oct 2013 → Today - Laboratory Experimental Medicine and Pediatrics (LEMP) (Research group)
Member
From1 Oct 2003 → 30 Sep 2013 - Primary and interdisciplinary care Antwerp (ELIZA) (Research group)
Member
From1 Oct 2003 → 30 Sep 2008
Projects
21 - 30 of 32
- INFLA-MED - Fundamental research in the pathophysiological processes of inflammatory diseases.From1 Jan 2015 → 31 Dec 2019Funding: BOF - Other initiatives, Fund Recuperation Fiscal Exemption
- Study of the neuroimmune modulation within the gastrointestinal tract during sepsis: a translational approach.From1 Jan 2015 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
- Characterization and modulation of the enteric neuroimmune environment during septic ileus.From1 Oct 2014 → 31 Jul 2016Funding: FWO fellowships
- The role of mucosal mediators and their effect on neuronal afferent signalling and intestinal permeability during postinflammatory visceral hypersensitivity: a translational study.From1 Oct 2014 → 30 Sep 2018Funding: BOF - Doctoral projects
- The role of afferent neurons and their modulation in the pathogenesis of postinflammatory gastrointestinal motility and sensitivity disturbances.From1 Jan 2013 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
- Role of dendritic cells in Th1/Th17-mediated immune diseases.From1 Jan 2013 → 31 Dec 2016Funding: BOF - Concerted Research Project from 1994
- Innovative imaging techniques to predict treatment outcome in pediatric obstructive sleep apnea.From1 Oct 2012 → 30 Sep 2017Funding: FWO fundamental clinical research fellowship
- The role of afferent nerves in the pathogenesis of post-inflammatory gastrointestinal motility and sensitivity disturbances in the rat.From1 Oct 2012 → 31 Jul 2014Funding: FWO fellowships
- Characterisation and modulation of the enteric neuroimmune environment during endotoxin-induced ileus.From1 Oct 2012 → 30 Sep 2014Funding: FWO fellowships
- The role of afferent nerves in the pathogenesis of postinflammatory gastrointestinal motility and sensitivity disturbances in the rat.From1 Oct 2010 → 30 Sep 2012Funding: FWO fellowships
Publications
1 - 10 of 164
- Novel insights in the clinical evaluation and management of childhood obesity(2024)
Authors: Eline Vermeiren, Stijn Verhulst, Kim Van Hoorenbeeck, Benedicte De Winter, Annelies Van Eyck, Luc Bruyndonckx
Number of pages: 251 - Epidemiological characteristics of a population visiting a patient-centered informative website about irritable bowel syndrome(2023)
Authors: Kathleen Van Malderen, Joris De Man, Benedicte De Winter, Heiko De Schepper
Pages: 17 - 25 - Measuring myeloperoxidase activity as a marker of inflammation in gut tissue samples of mice and rat(2023)
Authors: Nikita Hanning, Joris De Man, Benedicte De Winter
Pages: 1 - 9 - Prevalence, risk factors and diagnostic accuracy of non-invasive tests for NAFLD in people with type 1 diabetes(2023)
Authors: Jonathan Mertens, Jonas Weyler, Eveline Dirinck, Luisa Vonghia, Wilhelmus Kwanten, Laura Mortelmans, Cédric Peleman, Shivani Chotkoe, Maarten Spinhoven, Floris Vanhevel, et al.
Pages: 1 - 12 - Self-control training supplementing inpatient multidisciplinary obesity treatment in children and adolescents(2023)
Authors: Tiffany Naets, Eline Vermeiren, Leentje Vervoort, Marijke Ysebaert, Stijn Verhulst, Benedicte De Winter, Luc Bruyndonckx, Ann Tanghe, Ann De Guchtenaere, Sandra Verbeken, et al.
Pages: 1 - 12 - The role of adipose tissue and subsequent liver tissue hypoxia in obesity and early stage metabolic dysfunction associated steatotic liver disease(2023)
Authors: Annelies Van Eyck, Wilhelmus Kwanten, Cédric Peleman, Sanae Makhout, Steven Van Laere, Kim Van Hoorenbeeck, Joris De Man, Benedicte De Winter, Sven Francque, Stijn Verhulst
Pages: 1 - 11 - Aberrant mucin expression profiles associate with pediatric inflammatory bowel disease presentation and activity(2023)
Authors: Tom Breugelmans, Wout Arras, Lauren-Emma Boen, Eliah Borms, Lisa Kamperdijk, Joris De Man, Els Van de Vijver, Benedicte De Winter, Nicolette Moes, Annemieke Smet
Pages: 589 - 601 - Novel insights in bronchopulmonary dysplasia(2023)
Authors: Kristien Vanhaverbeke, Stijn Verhulst, Antonius Mulder, Benedicte De Winter, Kevin Lamote, Kim Van Hoorenbeeck, Annelies Van Eyck
Number of pages: 324 - IL-22-activated MUC13 impacts on colonic barrier function through JAK1/STAT3, SNAI1/ZEB1 and ROCK2/MAPK signaling(2023)
Authors: Tom Breugelmans, Wout Arras, Baptiste Oosterlinck, Aranzazu Jauregui, Michaël Somers, Bart Cuypers, Kris Laukens, Joris De Man, Heiko De Schepper, Benedicte De Winter, et al.
Pages: 1 - 25 - Exploring the role of transmembrane mucins in intestinal barrier dysfunction in inflammatory bowel diseases(2023)
Authors: Tom Breugelmans, Annemieke Smet, Benedicte De Winter, Heiko De Schepper, Joris De Man
Number of pages: 285
Patents
1 - 9 of 9
- Method for determining the severity and prognosis of rsv infection (Inventor)
- Mucins and isoforms thereof in diseases characterized by barrier dysfunction (Inventor)
- Mucin isoforms in diseases characterized by barrier dysfunction (Inventor)
- Mucins and isoforms thereof in diseases characterized by barrier dysfunction (Inventor)
- Method for determining the severity and prognosis of RSV infection (Inventor)
- Bis(acetamidophenyl) guanidinophenyethylphosphonates for use in the prevention and/or treatment of PAR-related diseases. (Inventor)
- Mucin isoforms in diseases characterized by barrier dysfunction (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)